thiazoles has been researched along with Central Nervous System Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SF; Chuang, YC; Kuo, HC; Liao, CH; Wang, CC | 1 |
| Al-Awadhi, FH; Chen, QY; Elsadek, LA; Luesch, H; Ratnayake, R; Salvador-Reyes, LA | 1 |
| Chen, SF; Kuo, HC | 1 |
| Kumari, S; Mishra, CB; Tiwari, M | 1 |
| Ezawa, N; Ikeda, S; Kametani, F; Oguchi, K; Sekijima, Y; Watanabe, M; Yahikozawa, H; Yamada, M; Yazaki, M; Yoshinaga, T | 1 |
| Fujimori, S; Hada, T; Hisashi, Y; Hosoya, T; Kamatani, N; Kenjiro, K; Kohri, K; Matsuzawa, Y; Nakamura, T; Naoyuki, K; Shin, F; Takanori, U; Tatsuo, H; Tetsuya, Y; Toshikazu, H; Toshitaka, N; Ueda, T; Yamamoto, T; Yamanaka, H; Yuji, M | 1 |
| Barbeito, L; Estevez, AG; Stutzmann, JM | 1 |
| Abdalla, RE; Haseeb, MA; Iskander, S | 1 |
1 review(s) available for thiazoles and Central Nervous System Disease
| Article | Year |
|---|---|
Thiazole: a promising heterocycle for the development of potent CNS active agents.
Topics: Animals; Central Nervous System Agents; Central Nervous System Diseases; Heterocyclic Compounds; Humans; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2015 |
2 trial(s) available for thiazoles and Central Nervous System Disease
| Article | Year |
|---|---|
Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system Disorders-A cohort study.
Topics: Acetanilides; Aged; Aged, 80 and over; Central Nervous System Diseases; Cognition; Cohort Studies; Drug Therapy, Combination; Humans; Middle Aged; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2022 |
Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Topics: Adult; Central Nervous System Diseases; Dental Enamel; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Japan; Kidney Diseases, Cystic; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase | 2011 |
5 other study(ies) available for thiazoles and Central Nervous System Disease
| Article | Year |
|---|---|
Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases.
Topics: Animals; Brain; Cell Line, Tumor; Central Nervous System Diseases; Depsipeptides; Glioblastoma; Histone Deacetylase Inhibitors; Mice; Thiazoles | 2020 |
Therapeutic efficacy of low-dose (25 mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseases.
Topics: Acetanilides; Aged; Central Nervous System Diseases; Dementia; Female; Humans; Male; Parkinson Disease; Stroke; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2019 |
Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis.
Topics: Aniline Compounds; Central Nervous System Diseases; Cerebral Amyloid Angiopathy, Familial; Female; Humans; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Prealbumin; Retrospective Studies; Thiazoles; Time Factors | 2016 |
Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cell Survival; Cells, Cultured; Central Nervous System Diseases; Drug Interactions; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Glutamic Acid; Kainic Acid; Motor Neurons; N-Methylaspartate; Rats; Receptors, Amino Acid; Riluzole; Thiazoles | 1995 |
Further observations on the use of ambilhar in the treatment of schistosomiasis mansoni in the Sudan.
Topics: Adolescent; Adult; Anthelmintics; Central Nervous System Diseases; Child; Drug Hypersensitivity; Feces; Female; Humans; Imidazoles; Male; Phenobarbital; Schistosomiasis; Sudan; Thiazoles | 1968 |